The CBGM sensor lead was placed intravascularly via a percutaneous ... Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities ...
The CBGM sensor lead was placed intravascularly ... This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
The CBGM sensor lead was placed intravascularly via a percutaneous ... This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
The CBGM is designed to be a long-term implantable ... please visit This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of ...
Glucotrack's CBGM is a long-term, implantable system that continually ... Forward-Looking Statements This news release contains forward-looking statements within the meaning of the Private Securities ...
Glucotrack’s CBGM is a long-term ... statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E ...
Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...
Glucotrack’s CBGM is a long-term ... please visit This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback